- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05275959
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
Implementation Research on the Construction and Scale Up Regarding To"Comorbidity-Co-causes-Joint-prevention" Comprehensive Demonstration District of Myopia and Obesity Among Children and Adolescents in Beijing Guided by RE-AIM Framework
Study Overview
Status
Detailed Description
Baseline (March-April 2023), first follow-up (July-August 2023), and second follow-up (November-December 2023). The collection of data from study participants at baseline and third follow-up included questionnaire collection, anthropometric indicators, body composition measurements, vision measurements, blood pressure measurements, urine, saliva, and venous blood draws, as well as home questionnaires, school questionnaires, and interventionist physician questionnaires from the community hospitals and the project hospitals; and the first follow-up (the collection of data varied in each district, and was done according to the level of district cooperation) included questionnaire collection, anthropometric measurements, vision measurements, and blood pressure measurements, as well as home questionnaires, school questionnaires, and interventionist physician questionnaires from the community hospitals and the project hospitals.
Myopia and activity records: including nighttime lighting, wake-sleep cycles, and movement. As well as family questionnaires, school questionnaires, community hospitals and project hospital intervention doctor questionnaires. All inspection items are operated by trained and qualified doctors and professional health technicians. The inspection will be arranged in the school, and the whole process is the same as the regular physical examination in the school.
The child required 2 venous blood collections, urine and saliva collections during the year (at the initial stage and at the 3rd follow-up, respectively).
Blood sample testing: 10ml of venous blood is drawn each time for blood routine and blood biochemistry. The blood process is safe. Blood samples include: blood biochemical indicators (fasting blood glucose (FBG), insulin, total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) ) and so on).
Hormone testing: Collect saliva samples in the morning and purchase ELISA kits to measure levels of thyroid hormones, estradiol and testosterone.
Urine sample testing: use polypropylene urine cups and urine collection tubes (without PAEs plasticizers) to collect 10 mL of urine from the research subjects, and reserve the sample to collect the first excretion after getting up in the morning, before breakfast and before exercising. The collected urine samples were uniformly stored in a 5mL centrifuge tube and stored in a -20°C refrigerator. Urine PAEs and their metabolites: Ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was used to detect seven PAEs metabolites in students' urine: monomethyl phthalate (MMP), phthalic acid Monoethyl ester (MEP), mono-n-butyl phthalate (MBP), mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-phthalate) Hydroxyhexyl) ester (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP).
The content of the family and student questionnaires will include general conditions of children, general conditions of parents and families, as well as daily diet, physical activity and sleep. The name of the child will only be used for tracking and will be deleted after one year of observation to ensure that the information of the child and participants will not be leaked. All members of the project team have signed a confidentiality agreement, and all information in the questionnaire will not be leaked to the outside world.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Beijing, China
- Dongcheng Primary and Secondary School Health Care Center
-
Beijing, China
- Health Education Center forPrimary and Secondary Schools Changping
-
-
Beijing
-
Beijing, Beijing, China, 101100
- Tongzhou District Primary and Secondary School Health Care Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- At 6-14 years old。
- The physical examination information at school is complete.
- There is no transfer plan within one year.
Exclusion Criteria:
- There are ophthalmic device diseases, such as keratitis, corneal ulcer, etc.;
- History of ophthalmic surgery, such as laser surgery;
- Visual problems such as color weakness and color blindness;
- History of heart disease, hypertension, diabetes, tuberculosis, asthma, hepatitis, or nephritis;
- Obesity caused by endocrine diseases or side effects of drugs;
- Abnormal physical development, such as dwarfism or gigantism;
- Can not participate in school sports activities;
- Have any weight loss behaviors such as inducing vomiting or taking weight loss drugs in past three months;
- Body deformities, such as severe scoliosis, chicken breasts, limps, pronounced O-or X-legs.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: "22510SS" Intervention
Intervention measures will be taken against children and adolescents' myopia and obesity at four levels: individual (individual centered activities), environment (supportive family and school settings), and supervision (family, school, program team, and clinical) and feedback (timely feedback from the WeChat applet).
|
Myopia and obesity in children and adolescents have become serious public health problems that endanger public health, especially in China.
Unhealthy lifestyle behaviors are environmental drivers of both myopia and obesity.
This protocol describes a study to evaluate the effectiveness of "22510SS", that is 2 h of daytime outdoor activities ('2'); Limit screen time to no more than 2 h per day ('2'); Consume at least 5 servings of fruits and vegetables daily ('5'); Attain 1 h of physical activity daily ('1'); Consume 0 sugar-sweetened beverages ('0'); Reasonable sleep duration ('S'); Regular supervision ('S').
A school-based, multifaceted intervention strategy for myopia and obesity prevention, and to assess and explore the implementation of "22510SS" with regards to acceptability, feasibility, adoption, usage and maintenance.
Other Names:
|
|
No Intervention: Control
Regular health education without extra intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Myopia changes
Time Frame: Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
Refer to the "Guidelines for the Prevention and Control of Myopia in Children and Adolescents" issued by the National Health Commission in 2019 to check the vision of children.
Unaided distance visual acuity should be measured from a standard distance (5 m), using a standard chart of Illiterate E with a white background.
The reduced VA was defined as the measurement value of less than 5.0 in either eye.
Then, myopia was defined when participants had reduced VA and had spherical equivalent (SE) less than -0.50 D using non-cycloplegic and subjective refraction.
Mild myopia was defined as the SE less than -0.50 D but greater than or equal to -3.00 D, moderate myopia was defined as less than -3.00 D but greater than or equal to -6.00 D, and severe myopia was defined as less than -6.00 D.
|
Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Height changes
Time Frame: Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
The record is in centimeters and accurate to one decimal place.
|
Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Weight changes
Time Frame: Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
Use an electronic scale and check its accuracy and sensitivity before use.
The accuracy error shall not exceed 0.1%, that is, the error per 100kg shall be less than 0.1kg.
|
Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Waist circumference changes
Time Frame: Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
A tape ruler was used to measure horizontally around the midpoint of the line between the anterior superior iliac crest and the lower edge of the 12th rib (the thickest part of the waist was selected for obese patients);
|
Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Hip circumference changes
Time Frame: Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
The subject stands naturally, with the arms drooping and moderately spread, the feet together, the legs are evenly weighted, the hips are relaxed, and the eyes are straight ahead.
The tester places the tape on the most protruding part of the back of the buttocks, and circles the buttocks horizontally.
During the test, the tape measure should be close to the skin, and the soft tissue should not be pressed.
The reading should be taken when the subject exhales calmly.
To ensure that the position of the tape ruler is correct, you can move the tape ruler up and down, compare the readings at different positions, and record the maximum value.
|
Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Body composition changes
Time Frame: Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
The body composition measurement was conducted using the Tanita BC-420 body composition analyzer, which collects data on body fat percentage.
The participants stood on the foot electrodes of the analyzer and held the hand electrode firmly while maintaining a stable posture throughout the process.
The measurement was completed using the bio-electrical impedance method, which typically took between 40 to 60 seconds to obtain accurate readings of the aforementioned body composition metrics.
|
Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Blood pressure changes
Time Frame: Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
The upper arm medical electronic sphygmomanometer is used to measure blood pressure.
During the measurement, the cuff of the sphygmomanometer is securely wrapped around the upper arm at the level of the heart, ensuring a proper fit without constriction.
The device is then activated to inflate the cuff, applying pressure to the brachial artery until the pulse is no longer detectable.
The pressure is gradually released, and the device records the systolic pressure (the maximum pressure in the arteries during the heart's contraction) and the diastolic pressure (the minimum pressure in the arteries during the heart's relaxation).
|
Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Blood glucose change
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
Blood glucose analysis was conducted using a professional method to evaluate the blood sample.
First, a skilled nurse performed venipuncture to collect the blood samples from the participants.
The collected blood samples were immediately frozen and stored in a -80℃ freezer until all samples were gathered for unified delivery to the laboratory.
The blood samples were sent to a specialized testing center for analysis and result feedback.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Total cholesterol change
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
Total cholesterol analysis was conducted using a professional method to evaluate the blood sample.
First, a skilled nurse performed venipuncture to collect the blood samples from the participants.
The collected blood samples were immediately frozen and stored in a -80℃ freezer until all samples were gathered for unified delivery to the laboratory.
The blood samples were sent to a specialized testing center for analysis and result feedback.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Low-density lipoprotein cholesterol (LDL-C) change
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
Low-density lipoprotein cholesterol (LDL-C) was conducted using a professional method to evaluate the blood sample.
First, a skilled nurse performed venipuncture to collect the blood samples from the participants.
The collected blood samples were immediately frozen and stored in a -80℃ freezer until all samples were gathered for unified delivery to the laboratory.
The blood samples were sent to a specialized testing center for analysis and result feedback.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
High density lipoprotein cholesterol (HDL-C) change
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
High density lipoprotein cholesterol (HDL-C) change was conducted using a professional method to evaluate the blood sample.
First, a skilled nurse performed venipuncture to collect the blood samples from the participants.
The collected blood samples were immediately frozen and stored in a -80℃ freezer until all samples were gathered for unified delivery to the laboratory.
The blood samples were sent to a specialized testing center for analysis and result feedback.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Triglycerides change
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
Triglycerides was conducted using a professional method to evaluate the blood sample.
First, a skilled nurse performed venipuncture to collect the blood samples from the participants.
The collected blood samples were immediately frozen and stored in a -80℃ freezer until all samples were gathered for unified delivery to the laboratory.
The blood samples were sent to a specialized testing center for analysis and result feedback.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Uric acid change
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
Uric acid was conducted using a professional method to evaluate the blood sample.
First, a skilled nurse performed venipuncture to collect the blood samples from the participants.
The collected blood samples were immediately frozen and stored in a -80℃ freezer until all samples were gathered for unified delivery to the laboratory.
The blood samples were sent to a specialized testing center for analysis and result feedback.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Saliva test
Time Frame: Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
Professional salivary hormone detection methods were employed to analyze the saliva samples from participants.
First, participants were instructed to collect saliva samples at a specified time point, typically upon waking in the morning.
Collected saliva samples were stored in sterile containers and refrigerated promptly to prevent hormone degradation.
Estradiol was measured from the saliva sample.
The testing methods utilized high-sensitivity enzyme-linked immunosorbent assays (ELISA) to ensure precise and reliable results.
|
Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Urine sample detection changes
Time Frame: Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
Use polypropylene urine cups and urine collection tubes (without PAEs plasticizers) to collect 10 mL of urine from the research subjects, and reserve the sample to collect the first excretion after getting up in the morning, before breakfast and before exercising.
The collected urine samples were uniformly stored in a 5mL centrifuge tube and stored in a -20°C refrigerator.
Urine PAEs and their metabolites: Ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was used to detect seven PAEs metabolites in students' urine: monomethyl phthalate (MMP), phthalic acid Monoethyl ester (MEP), mono-n-butyl phthalate (MBP), mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-phthalate) Hydroxyhexyl) ester (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP).
|
Approximate timing: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Sleep diary
Time Frame: Approximate timing: Measured in the six month of intervention
|
To understand students' sleep duration, data collection was conducted using sleep diaries.
Each participant was required to record at least one school day and one weekend day consecutively.
The sleep diary primarily recorded bedtime, actual sleep onset time, and morning wake-up time.
These data were used to calculate total sleep duration per night.
|
Approximate timing: Measured in the six month of intervention
|
|
Night lighting changes
Time Frame: Approximate timing: Measured in the third month of intervention
|
Put the photometer on the bedside table of the bedroom and program it to continuously collect light information every 60 seconds.
|
Approximate timing: Measured in the third month of intervention
|
|
Basic information-for student
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of student questionnaire, which was filled by students or with the help of their parents.
Basic information includes students' school, grade, class, name, gender, and date of birth.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Knowledge mastery-for student
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of student questionnaire, which was filled by students or with the help of their parents.
The knowledge mastery part assessing health knowledge focus on whether students can distinguish behaviors include key message of '22510ss' that promote health.
Responses were categorized as "Correct" "Incorrect" or "Don't Know" The total score is the sum of each item (0 to 7), "Correct" for 1 point, and "Incorrect" "Don't Know" for 0 point.
A higher total score indicates a better understanding of health knowledge.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Behavior practice-for student
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of student questionnaire, which was filled by students or with the help of their parents.
The health behavior section of the questionnaire surveys students on their screen time, consumption of fruits and vegetables, intake of high-quality protein, frequency of consuming sugary drinks, and frequency of vision and weight measurement.
We calculate the score of '22510ss' key healthy behavior based on their questionnaire results.
Each behavior earns one point for completion, and the total score for the items is calculated.
The highest score is 7 points, and the lowest is 0 point.
Higher points indicate stronger health action capabilities among students.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Myopia and obesity intervention promotion/barrier factors-for student
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of student questionnaire, which was filled by students or with the help of their parents.
This section of the questionnaire investigates factors that promote or hinder students' implementation of healthy behaviors, including school support, family influence, and peer influence.
A five-point Likert scale ("Strongly Agree" is scored 5 points, and "Strongly Disagree" is scored 1 point) is used, and if more than 75% of respondents choose "Agree" or "Strongly Agree," the factor is considered to have a strong promoting or hindering effect.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Dietary questionnaire-for student
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of student questionnaire, which was filled by students or with the help of their parents.
We used DQQ-China (Dietary Quality Questionnaire for China) to assess the dietary quality of student.
DOQ collects dietary consumption data from 29 food groups and is used to calculate the Global Dietary Recommendation (GDR) score.
The GDR score ranges from 0 to 18 and reflects adherence to the global dietary guidelines proposed by the World Health Organization (WHO).
Higher GDR scores indicate better adherence to WHO's global dietary recommendations.
Dietary quality classification based on the GDR score is as follows: High dietary quality: GDR ≥ 10; Moderate dietary quality: 8 ≤ GDR < 10; Low dietary quality: GDR < 8.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Physical activity questionnaire-for student
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of student questionnaire, which was filled by students or with the help of their parents.
International Physical Activity Questionnaire (IPAQ) was used to assess physical activity levels, which includes the frequency, duration, and intensity of physical activities such as walking, moderate-intensity activities, and vigorous-intensity activities over the past 7 days, and the long form providing a more detailed assessment over a longer period.
The total physical activity score was usually calculated in terms of MET-minutes/week (Metabolic Equivalent of Task), Based on the MET values (<600, 600-1500, >1500), students' activity levels are classified as low, moderate, or high.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Sleep questionnaire-for student
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of student questionnaire, which was filled by students or with the help of their parents.
The Center for Epidemiologic Studies Depression Scale (CES-D) was employed, each question on the MEQ-5 is answered on a scale that reflects the degree of preference for morning or evening activity.
The scores from the five items are summed up to generate an overall score that reflects the individual's chronotype: The total score of the MEO-5 ranges from 4 to 25.
The scoring categories are as follows: 4-7 points: Definitely Evening Type; 8-11 points: Moderately Evening Type; 12-17 points: Intermediate Type; 18-21 points: Moderately Morning Type;22-25 points: Definitely Morning Type.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Mental health questionnaire-for student
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of student questionnaire, which was filled by students or with the help of their parents.
The Center for Epidemiologic Studies Depression Scale (CES-D) was employed to assess the frequency and severity of depressive symptoms The CES-D consists of 20 items using a 4-point Likert scale (0 = "Rarely or none of the time," 3 = "Most or all of the time").
Scores for each item are summed, with higher total scores indicating more severe depressive symptoms.
The total score ranges from 0 to 60.
Generally, a score of 16 or higher is considered indicative of clinically significant depressive symptoms.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Basic information -for patents
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of parents' questionnaire.
Basic information includes their child's school, grade, class, name, gender, and date of birth, as well as their relationship, sibling information, birth information of the child, and the parents' age.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Myopia and obesity status-for patents
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of parents' questionnaire.
This section surveys the height, weight, vision status, and the presence of diseases such as hypertension and diabetes in the father and mother.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Knowledge mastery-for patents
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of parents' questionnaire.
The knowledge mastery part assessing health knowledge focus on whether students can distinguish behaviors include key message of '22510ss' that promote health.
Responses were categorized as "Correct" "Incorrect" or "Don't Know" The total score is the sum of each item (0 to 7), "Correct" for 1 point, and "Incorrect" "Don't Know" for 0 point.
A higher total score indicates a better understanding of health knowledge.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Behavior practice-for patents
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of parents' questionnaire.
The health behavior section of the questionnaire surveys parents on their screen time, consumption of fruits and vegetables, intake of high-quality protein, frequency of consuming sugary drinks, and frequency of vision and weight measurement.
We calculate the score of '22510ss' key healthy behavior based on their questionnaire results.
Each behavior earns one point for completion, and the total score for the items is calculated.
The highest score is 7 points, and the lowest is 0 point.
Higher points indicate stronger health action capabilities among students.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Child sleep quality-for patents
Time Frame: Approximate timing: Measured in the baseline and the twelfth month of intervention
|
This is part of parents' questionnaire.
This section of the questionnaire surveys parents about their child's sleep performance using Sleep Disturbance Scale for Children (SDSC).
The SDSC consists of 26 items that cover various aspects of sleep, categorized into different domains, it uses a 5-point Likert scale (1 = "never," 5 = "always"), where parents report how often their child experiences each symptom.
The scores are summed to generate a total score and sub-scores for each domain.
Total score range of 26 to 130, we used the following thresholds to classify the severity of sleep disturbances: Score < 38: Considered no significant sleep disturbance; Scores between 38 and 45: Mild sleep disturbance; Score > 45: Significant sleep disturbance.
|
Approximate timing: Measured in the baseline and the twelfth month of intervention
|
|
Basic information -for doctors of school
Time Frame: Approximate timing: Measured in the sixth month of intervention
|
This is part of school questionnaire.
Basic information includes the school doctors' gender, age, education level, and workplace.
|
Approximate timing: Measured in the sixth month of intervention
|
|
Promotion/barrier factors in health working --for doctors of school
Time Frame: Approximate timing: Measured in the sixth month of intervention
|
This is part of school questionnaire.
We investigated the promoting and hindering factors in schools' efforts to improve students' health behaviors, including items such as the school's educational philosophy, school environment, and level of school support.
The items are scored using a 5-point Likert scale ("Strongly Agree" is scored 5 points, and "Strongly Disagree" is scored 1 point).
If more than 50% of school doctors select "Strongly Agree" for a particular item, it is considered an important promoting or hindering factor.
|
Approximate timing: Measured in the sixth month of intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Yi Song2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly